Replimune Group, Inc. Stockholders Equity

Quick Answer

Replimune Group, Inc. reported Stockholders Equity of $415.84 million for fiscal year 2025.

Replimune Group, Inc. Stockholders Equity — Annual History

Fiscal Year Stockholders Equity YoY Change
2025 $415.84M +11.0%
2024 $374.51M -32.6%
2023 $555.29M +35.0%
2022 $411.23M -17.5%
2021 $498.73M +171.5%
2020 $183.72M +33.3%
2019 $137.86M +591.2%
2018 -$28.07M -143.8%
2017 -$11.52M

Quarterly Stockholders Equity

Quarter Ending Stockholders Equity YoY QoQ
December 31, 2025 $210.54M -56.4% -20.0%
September 30, 2025 $263.34M -31.0% -21.8%
June 30, 2025 $336.71M -21.0% -19.0%
March 31, 2025 $415.84M +11.0% -13.8%
December 31, 2024 $482.37M +14.4% +26.5%
September 30, 2024 $381.46M -18.0% -10.6%
June 30, 2024 $426.45M -17.0% +13.9%
March 31, 2024 $374.51M -32.6% -11.2%
  • Replimune Group, Inc. showed an increase of +11.0% in Stockholders Equity compared to the prior fiscal year.
  • Over the 2017–2025 period, Replimune Group, Inc.’s stockholders equity has grown by 3711.3% (from -$11.52 million to $415.84 million).
  • The most recent figure is from Replimune Group, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on May 22, 2025.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment